These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28658133)

  • 21. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions.
    Benevolo M; Mottolese M; Marandino F; Vocaturo G; Sindico R; Piperno G; Mariani L; Sperduti I; Canalini P; Donnorso RP; Vocaturo A
    Mod Pathol; 2006 Mar; 19(3):384-91. PubMed ID: 16415792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
    Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH
    Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
    Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
    Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.
    Lee M; Chang MY; Shin HY; Shin E; Hong SW; Kim KM; Chay DB; Cho H; Kim JH
    Medicine (Baltimore); 2016 Jan; 95(3):e2425. PubMed ID: 26817873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
    Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
    BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
    Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR
    Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance.
    Guo M; Warriage I; Mutyala B; Patel S; Lin E; Gong Y; Sneige N
    Diagn Cytopathol; 2011 Jul; 39(7):482-8. PubMed ID: 20607682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
    Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
    Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.
    Griffin H; Soneji Y; Van Baars R; Arora R; Jenkins D; van de Sandt M; Wu Z; Quint W; Jach R; Okon K; Huras H; Singer A; Doorbar J
    Mod Pathol; 2015 Jul; 28(7):977-93. PubMed ID: 25953390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV L1 and P16 Expression in CIN1 to Predict Future CIN2.
    Liu C; Du H; Wang C; Belinson JL; Yang B; Zhang W; Tang J; Wu R
    Int J Gynecol Pathol; 2017 May; 36(3):281-288. PubMed ID: 28277314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
    Capobianco G; Marras V; Wenger JM; Santeufemia DA; Ambrosini G; Lutzoni R; Dessole M; Cherchi PL
    Eur J Gynaecol Oncol; 2013; 34(3):227-30. PubMed ID: 23967551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
    Solares C; Velasco J; Álvarez-Ruiz E; González-Fernández L; Encinas AI; Astudillo A; Schneider J
    Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study.
    White CM; Bakhiet S; Bates M; Ruttle C; Pilkington LJ; Keegan H; O'Toole SA; Sharp L; O'Kelly R; Tewari P; Flannelly G; Martin CM; O'Leary JJ;
    Cancer Epidemiol; 2020 Oct; 68():101793. PubMed ID: 32841926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
    Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 37. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.
    Kong CS; Balzer BL; Troxell ML; Patterson BK; Longacre TA
    Am J Surg Pathol; 2007 Jan; 31(1):33-43. PubMed ID: 17197917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.
    Polman NJ; Uijterwaal MH; Witte BI; Berkhof J; van Kemenade FJ; Spruijt JW; van Baal WM; Graziosi PG; van Dijken DK; Verheijen RH; Helmerhorst TJ; Steenbergen RD; Heideman DA; Ridder R; Snijders PJ; Meijer CJ
    Int J Cancer; 2017 Jan; 140(2):423-430. PubMed ID: 27677098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CIN grades possessing different HPV RNA location patterns and RNAscope is helpful tool for distinguishing squamous intraepithelial lesions in difficult cervical cases.
    Chen R; Zhang R; Zhang M; Liu S; Xie M; Yang Z; Shi Q; Chen H; Xiong H; Wang N; Jiang Q
    Diagn Pathol; 2023 Feb; 18(1):23. PubMed ID: 36797728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias.
    Venturoli S; Ambretti S; Mirasoli M; Santini D; Zerbini M; Roda A; Musiani M
    Int J Gynecol Pathol; 2008 Oct; 27(4):575-81. PubMed ID: 18753961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.